Internal Med Medical News about micafungin

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

5. Rapid correction of low vitamin D status in nursing home residents

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected intensive care unit-acquired candidemia among patients with sepsis: a model simulation
Critical Care, 07/02/09

Zilberberg MD et al. - Recent epidemiologic literature indicates that candidal species resistant to azoles are becoming more prevalent in the face of increasing incidence of hospitalizations with candidemia. Given the increasing likelihood of azole resistance among candidal isolates, empiric treatment of ICU-AC with 100 mg daily MIC is a cost effective alternative to FLU.

<< Previous
Salvage Treatment for Persistent Methicillin-Resistant...

Next >>
Cystic Fibrosis Related Diabetes: Current Trends in Prevalence,...